Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth.

Colossal has made headlines in the past for its plans to bring back the woolly mammoth, the thylacine — commonly referred as the Tasmanian tiger — and the dodo bird. The Texas-based company ...

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.

Colossal Biosciences announced Wednesday it had raised $200 million in Series C funding round led by TWG Global for its mission to bring back the woolly mammoth, dodo and thylacine (also commonly ...